.png){kind=small}
.png){kind=small}
در این صفحه کتاب ها، مقاله ها، گزارشات و اسلایدهای کارگاه های برگزار شده را می توانید دانلود نمائید.
1- کتاب تجربه راه اندازی مطالعه کوهورت شهرکرد 1398
2- مقالات منتشر شده از مطالعه کوهورت شهرکرد در پاب مدPubMed:
1- مقاله پروتکل و PDF - 2- مقاله پروفایل ، PDF -3- مقاله پروفایل، CDPD - 4- مقاله براورد خطر ده ساله بیماریهای قلبی عروقی، 5- مقاله استرس، 6- مقاله کیفیت زندگی، 7- مقاله نابرابری های اجتماعی اقتصادی در فشارخون بالا، 8- مقاله شیوع کمردرد، 9- مقاله دیابت و پره دیابت، 10- مقاله اصلاحات مورد نیاز در نظام سلامت،
11- مقاله گزارش فلزات منجر به سقط جنین در استان
-
Publications
Papers:
3- The protocol of a population-based prospective cohort study in southwest of Iran to analyze common non-communicable diseases: Shahrekord cohort study
6- Study of correlation between chronic stressor, biochemical markers and hematologic indices in Shahrekord Cohort Study: A population-based cross-sectional study
8- Quality of life and its related factors among participants in Shahrecord – Iran cohort study
11- Socioeconomic gradient in physical activity: findings from the PERSIAN cohort study
13- The PERSIAN Cohort: Providing the Evidence Needed for Healthcare Reform
27-Repositioning of the global epicentre of non-optimal cholesterol
28- Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants. Lancet. 2020;396(10261):1511–24.
3- اسلایدهای آموزشی
| کاربرد AI در کوهورت | جزوه ترجمان دانش مطالعه کوهورت شهرکرد1401 و ابلاغیه | کارگاه 1 کوهورت 1404 | کارگاه 3 کوهورت 1404 | ||||||
| جزوه بیماریهای خاص | کارگاه 2 کوهورت 1404 |
لیست سایر مقالات منتج از مطالعه کوهورت پرشین شهرکرد (1-62)
1. Repositioning of the global epicentre of non-optimal cholesterol. Nature. 2020;582(7810):73–7.
2. Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants. Lancet. 2020;396(10261):1511–24.
3. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. Elife. 2021;10.
4. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80.
5. Ahmadi A, Etemad K, Khaledifar A. Risk factors for heart failure in a cohort of patients with newly diagnosed myocardial infarction: a matched, case-control study in Iran. Epidemiol Health. 2016;38:e2016019.
6. Ahmadi A, Fadaei Y, Shirani M, Rahmani F. Modeling and forecasting trend of COVID-19 epidemic in Iran until May 13, 2020. Med J Islam Repub Iran. 2020;34:27.
7. Ahmadi A, Hashemi Nazari SS, Mobasheri M. Does ethnicity affect survival following colorectal cancer? A prospective, cohort study using Iranian cancer registry. Med J Islam Repub Iran. 2014;28:83.
8. Ahmadi A, Khaledifar A, Etemad K. Modeling of in hospital mortality determinants in myocardial infarction patients, with and without stroke: A national study in Iran. J Res Med Sci. 2016;21:74.
9. Ahmadi A, Khaledifar A, Sajjadi H, Soori H. Relationship between risk factors and in-hospital mortality due to myocardial infarction by educational level: a national prospective study in Iran. Int J Equity Health. 2014;13:116.
10. Ahmadi A, Kheiril S, Mohammadian-Hafshejani A, Raeisi H, Mosavi M, Sharifi H. The accuracy of "Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: A modelling analysis based on overseas cases and air travel data". Int J Infect Dis. 2020;95:319–20.
11. Ahmadi A, Mobasheri M, Hashemi-Nazari SS, Baradaran A, Choobini ZM. Prevalence of hypertension and type 2 diabetes mellitus in patients with colorectal cancer and their median survival time: A cohort study. J Res Med Sci. 2014;19(9):850–4.
12. Ahmadi A, Mosavi-Jarrahi A, Pourhoseingholi MA. Mortality determinants in colorectal cancer patients at different grades: a prospective, cohort study in Iran. Asian Pac J Cancer Prev. 2015;16(3):1069–72.
13. Ahmadi A, Noroozi M, Pourhoseingholi MA, Hashemi-Nazari SS. Effect of metabolic syndrome and its components on survival in colorectal cancer: a prospective study. J Renal Inj Prev. 2015;4(1):15–9.
14. Ahmadi A, Ramazani R, Rezagholi T, Yavari P. Incidence pattern and spatial analysis of breast cancer in Iranian women: Geographical Information System applications. East Mediterr Health J. 2018;24(4):360–7.
15. Ahmadi A, Salehi F. Evaluation of observed and the expected incidence of common cancers: An experience from Southwestern of Iran, 2010-2014. J Res Med Sci. 2018;23:4.
16. Ahmadi A, Salehi F, Ahmadimirghaed Z. Cancer trends in a province of Southwest of Iran, 2003-2016. J Res Med Sci. 2018;23:80.
17. Ahmadi A, Shirani M, Khaledifar A, Hashemzadeh M, Solati K, Kheiri S, et al. Non-communicable diseases in the southwest of Iran: profile and baseline data from the Shahrekord PERSIAN Cohort Study. BMC Public Health. 2021;21(1):2275.
18. Ahmadi A, Sodejani SA, Malekzadeh R, Poustchi H, Solati K. Study of correlation between chronic stressor, biochemical markers and hematologic indices in Shahrekord Cohort Study: A population-based cross-sectional study. Diabetes Metab Syndr. 2019;13(3):2170–4.
19. Ahmadi A, Soori H. Important statistical points to improve and promote the methodology of the articles on medical sciences, particularly nephrology and kidney; a review article. J Renal Inj Prev. 2015;4(1):4–8.
20. Ahmadi A, Soori H, Mehrabi Y, Etemad K. Spatial analysis of myocardial infarction in Iran: National report from the Iranian myocardial infarction registry. J Res Med Sci. 2015;20(5):434–9.
21. Ahmadi A, Soori H, Mehrabi Y, Etemad K, Khaledifar A. Epidemiological pattern of myocardial infarction and modelling risk factors relevant to in-hospital mortality: the first results from the Iranian Myocardial Infarction Registry. Kardiol Pol. 2015;73(6):451–7.
22. Ahmadi A, Soori H, Mehrabi Y, Etemad K, Sajjadi H, Sadeghi M. Predictive Factors of Hospital Mortality Due to Myocardial Infarction: A Multilevel Analysis of Iran's National Data. Int J Prev Med. 2015;6:112.
23. Ahmadi A, Soori H, Mehrabi Y, Etemad K, Samavat T, Khaledifar A. Incidence of acute myocardial infarction in Islamic Republic of Iran: a study using national registry data in 2012. East Mediterr Health J. 2015;21(1):5–12.
24. Ahmadi A, Soori H, Sajjadi H. Modeling of in hospital mortality determinants in myocardial infarction patients, with and without type 2 diabetes, undergoing pharmaco-invasive strategy: the first national report using two approaches in Iran. Diabetes Res Clin Pract. 2015;108(2):216–22.
25. Ahmadi A, Soori H, Sajjadi H, Nasri H, Mehrabi Y, Etemad K. Current status of the clinical epidemiology of myocardial infarction in men and women: a national cross-sectional study in iran. Int J Prev Med. 2015;6:14.
26. Akbari M, Poustchi H, Taherifard E, Mehrian SRA, Rahimian Z, Mesgarpour B, et al. Association of individual and community-level socioeconomic status and education with medication use: a multilevel analysis in the PERSIAN cohort. BMC Public Health. 2025;25(1):1842.
27. Amani S, Kheiri S, Ahmadi A. Honey versus diphenhydramine for post-tonsillectomy pain relief in pediatric cases: a randomized clinical trial. J Clin Diagn Res. 2015;9(3):Sc01–4.
28. Amini M, Moradinazar M, Rajati F, Soofi M, Sepanlou SG, Poustchi H, et al. Socioeconomic inequalities in prevalence, awareness, treatment and control of hypertension: evidence from the PERSIAN cohort study. BMC Public Health. 2022;22(1):1401.
29. Eghtesad S, Mohammadi Z, Shayanrad A, Faramarzi E, Joukar F, Hamzeh B, et al. The PERSIAN Cohort: Providing the Evidence Needed for Healthcare Reform. Arch Iran Med. 2017;20(11):691–5.
30. Fahimfar N, Eghtesad S, Poustchi H, Kohansal K, Sepanlou SG, Ostovar A, et al. Stepwise approach to screen high-risk individuals using the non-laboratory-based and laboratory-based CVD risk scoring. J Public Health (Oxf). 2025;47(4):728–36.
31. Hemati S, Mobini GR, Heidari M, Rahmani F, Soleymani Babadi A, Farhadkhani M, et al. Simultaneous monitoring of SARS-CoV-2, bacteria, and fungi in indoor air of hospital: a study on Hajar Hospital in Shahrekord, Iran. Environ Sci Pollut Res Int. 2021;28(32):43792–802.
32. Hosianpour F, Tehrani AM, Dehkordi AH, Ghaderi H. Quality of life and its related factors among participants in Shahrecord - Iran cohort study. Przegl Epidemiol. 2021;75(2):248–53.
33. Jorjani G, Roshandel G, Taherian MR, Mirbehbahani N, Moaddabshoar L, Ahmadi A, et al. Epidemiology and geographical patterns of common childhood cancers in Iran: Evidence from the National Cancer Registry. Cancer Epidemiol. 2024;93:102685.
34. Karyani AK, Matin BK, Soltani S, Rezaei S, Soofi M, Salimi Y, et al. Correction: Socioeconomic gradient in physical activity: findings from the PERSIAN cohort study. BMC Public Health. 2022;22(1):1713.
35. Kazemi Karyani A, Karmi Matin B, Soltani S, Rezaei S, Soofi M, Salimi Y, et al. Socioeconomic gradient in physical activity: findings from the PERSIAN cohort study. BMC Public Health. 2019;19(1):1312.
36. Khaledifar A, Hashemzadeh M, Solati K, Poustchi H, Bollati V, Ahmadi A, et al. The protocol of a population-based prospective cohort study in southwest of Iran to analyze common non-communicable diseases: Shahrekord cohort study. BMC Public Health. 2018;18(1):660.
37. Khamseh ME, Sepanlou SG, Hashemi-Madani N, Joukar F, Mehrparvar AH, Faramarzi E, et al. Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data from PERSIAN Cohort Study. Diabetes Ther. 2021;12(11):2921–38.
38. Khosravi Shadmani F, Amanollahi A, Zali A, Najafi F, Karami M, Moradi G, et al. Description of Epidemiological Features, Symptoms and Mortality of the Patients with COVID-19 in Some Provinces of Iran. Arch Iran Med. 2021;24(10):733–40.
39. Kiani FZ, Ahmadi A. Prevalence of different comorbidities in chronic obstructive pulmonary disease among Shahrekord PERSIAN cohort study in southwest Iran. Sci Rep. 2021;11(1):1548.
40. Kiani FZ, Ahmadi A. The Prevalence of Metabolic Syndrome, Scoring, and Comparison in People With and Without COPD: Evidence from Shahrekord PERSIAN Cohort Study. Metab Syndr Relat Disord. 2022;20(4):224–33.
41. Kiani FZ, Ahmadi A, Babadi AS, Rouhi H. Profile and preliminary results of Iranian sub cohort chronic obstructive pulmonary disease (COPD) in Shahrekord PERSIAN cohort in southwest Iran. BMC Pulm Med. 2021;21(1):105.
42. Mohammadbeigi A, Absari R, Valizadeh F, Saadati M, Sharifimoghadam S, Ahmadi A, et al. Sleep Quality in Medical Students; the Impact of Over-Use of Mobile Cell-Phone and Social Networks. J Res Health Sci. 2016;16(1):46–50.
43. Mohammadbeigi A, Moshiri E, Mohammadsalehi N, Ansari H, Ahmadi A. Dyslipidemia Prevalence in Iranian Adult Men: The Impact of Population-Based Screening on the Detection of Undiagnosed Patients. World J Mens Health. 2015;33(3):167–73.
44. Mohammadbeigi A, Valizadeh F, Mirshojaee SR, Ahmadli R, Mokhtari M, Ghaderi E, et al. Self-rated Health and Internet Addiction in Iranian Medical Sciences Students; Prevalence, Risk Factors and Complications. Int J Biomed Sci. 2016;12(2):65–70.
45. Moradi F, Heshmati J, Daneshzad E, Ahmadi A, Jafari T, Persad E, et al. Association between dietary satisfaction and depression, anxiety and stress in obese and overweight patients during the coronavirus pandemic. Clin Nutr ESPEN. 2021;45:399–403.
46. Najafi F, Pasdar Y, Matin BK, Rezaei S, Karyani AK, Soltani S, et al. Correction: Decomposing socioeconomic inequality in poor mental health among Iranian adult population: results from the PERSIAN cohort study. BMC Psychiatry. 2022;22(1):568.
47. Najafi F, Rezaei S, Hajizadeh M, Soofi M, Salimi Y, Kazemi Karyani A, et al. Decomposing socioeconomic inequality in dental caries in Iran: cross-sectional results from the PERSIAN cohort study. Arch Public Health. 2020;78:75.
48. Najafi F, Soltani S, Karami Matin B, Kazemi Karyani A, Rezaei S, Soofi M, et al. Socioeconomic - related inequalities in overweight and obesity: findings from the PERSIAN cohort study. BMC Public Health. 2020;20(1):214.
49. Najafi F, Soltani S, Matin BK, Karyani AK, Rezaei S, Soofi M, et al. Correction: Socioeconomic gradient in physical activity: findings from the PERSIAN cohort study. BMC Public Health. 2022;22(1):1944.
50. Nasri H, Behradmanesh S, Ahmadi A, Baradaran A, Nasri P, Rafieian-Kopaei M. Association of serum lipids with level of blood pressure in type 2 diabetic patients. J Renal Inj Prev. 2014;3(2):43–6.
51. Nasri H, Behradmanesh S, Maghsoudi AR, Ahmadi A, Nasri P, Rafieian-Kopaei M. Efficacy of supplementary vitamin D on improvement of glycemic parameters in patients with type 2 diabetes mellitus; a randomized double blind clinical trial. J Renal Inj Prev. 2014;3(1):31–4.
52. Pourfard H, Ahmadi A, Habibi Z, Asadi-Samani M, Shahinfard N, Soleimani A. The Effect of Tang Forte (Royal Jelly) Capsule on Hypoglycemia and Clinical Course in COVID-19 Patients Under Corticosteroid Therapy. J Evid Based Integr Med. 2023;28:2515690x231165333.
53. Rajabzadeh-Dehkordi M, Mohammadi-Nasrabadi F, Nouri M, Ahmadi A, Faghih S. Food insecurity, body mass index, socio-economic status, and food intake in lactating and non-lactating mothers with children under two years. BMC Nutr. 2023;9(1):62.
54. Rajabzadeh-Dehkordi M, Mohammadi-Nasrabadi F, Nouri M, Ahmadi A, Faghih S. Determinants and consequences of food insecurity in families having children under the age of 2 years. Nutr Health. 2024;30(4):687–96.
55. Sadeghi A, Boustani P, Mehrpour A, Asgari AA, Sharafkhah M, Yazdanbod A, et al. Prevalence and risk factors of gastroesophageal reflux disease in Iran: A cross-sectional analysis from the PERSIAN cohort. PLoS One. 2024;19(7):e0306223.
56. Sadeghi M, Ahmadi A, Baradaran A, Masoudipoor N, Frouzandeh S. Modeling of the relationship between the environmental air pollution, clinical risk factors, and hospital mortality due to myocardial infarction in Isfahan, Iran. J Res Med Sci. 2015;20(8):757–62.
57. Salehi F, Ahmadi A, Ahmadi Soodejani SS, Shahini Shams Abadi M. THE CHANGING TREND OF MORTALITY CAUSED BY GASTROINTESTINAL CANCERS IN IRAN DURING THE YEARS 2006-2010. Arq Gastroenterol. 2018;55(3):237–41.
58. Samaniyan Bavarsad P, Kheiri S, Ahmadi A. Estimation of the 10-Year Risk of Cardiovascular Diseases: Using the SCORE, WHO/ISH, and Framingham Models in the Shahrekord Cohort Study in Southwestern Iran. J Tehran Heart Cent. 2020;15(3):105–12.
59. Sepanlou S, Najafi F, Poustchi H, Parsaeian M, Ahmadi A, Somi M, et al. Prevalence, awareness, treatment, and control of hypertension based on ACC/AHA versus JNC7 guidelines in the PERSIAN cohort study. Sci Rep. 2022;12(1):4057.
60. Soofi M, Pasdar Y, Karami Matin B, Hamzeh B, Rezaei S, Kazemi Karyani A, et al. Socioeconomic-related inequalities in oral hygiene behaviors: a cross-sectional analysis of the PERSIAN cohort study. BMC Oral Health. 2020;20(1):63.
61. Tousizadeh S, Mohammadi-Moghadam F, Sadeghi R, Ahmadi A, Shakeri K. Investigation of the levels of essential and non-essential metals in women with and without abortion history: A study based on the Persian population of the Shahrekord cohort. Chemosphere. 2023;329:138434.
62. Zamani M, Poustchi H, Shayanrad A, Pourfarzi F, Farjam M, Noemani K, et al. Prevalence and determinants of anemia among Iranian population aged ≥35 years: A PERSIAN cohort-based cross-sectional study. PLoS One. 2022;17(2):e0263795.